Announcements Trials
Browse Landscape

Phase

Phase NA 218Phase 3 19Phase 2 7Phase 1 3Phase 4 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Stress Disorders, Post-Traumatic 1Small Cell Lung Carcinoma 1Depression 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Early Intervention, Educational × Clear all
NCT04548193 2024-08-28

Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship

Roswell Park Cancer Institute

Phase 1 Completed
49 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms

NCT01457469 2018-08-01

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer

Wake Forest University Health Sciences

Phase 1 Completed
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Tobacco Use Disorder, Small Cell Lung Carcinoma

NCT01672684 2014-10-17

Phase I: At-Home Support for Rural Women Using Group Video Calling

Stanford University

Phase 1 Completed
34 enrolled
Breast

Breast Neoplasms, Depression, Stress Disorders, Post-Traumatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡